Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tuesday, March 12, 2013 - 11:45am
tags:
Arena Pharmaceuticals, Sarepta, Ziopharm, Delcath, Aveo Pharmaceutical, United Therapeutics, AP Pharma, Titan Pharmaceuticals, Navidea Biopharmaceuticals, Biogen Idec, Raptor Pharmaceuticals
Opexa Therapeutics Poised For Breakout
Seeking Alpha
Tuesday, March 12, 2013 - 11:43am
tags:
Opexa, Toxavin
Oncothyreon Earnings: An Early Look
Motley Fool
Tuesday, March 12, 2013 - 11:42am
tags:
earnings, Oncothyreon
Biogen Idec says it filed for FDA approval of longer-lasting treatment for hemophilia A
Yahoo/AP
Tuesday, March 12, 2013 - 11:41am
tags:
Biogen Idec, FDA, hemophilia A, rFVIIIFc
Merck Says A Crucial Vytorin Study Will Continue
Pharmalot
Tuesday, March 12, 2013 - 11:38am
tags:
Vytorin, Merck, Zetia, Zocor
OncoGenex Loss Lower than Expected
Yahoo/Zacks
Tuesday, March 12, 2013 - 11:37am
tags:
OncoGenex, earnings
Don't Blame AbbVie for Humira's Success
Motley Fool
Tuesday, March 12, 2013 - 11:36am
tags:
AbbVie, Humira
Some Experts Defend Niacin For Heart Disease After Failed Study
Forbes
Tuesday, March 12, 2013 - 11:33am
tags:
niacin, Merck, Niaspan, AbbVie
Overseas Tax Savings for U.S. Drugmakers Under Threat
Bloomberg
Tuesday, March 12, 2013 - 11:28am
tags:
Pfizer, Merck, JNJ, Bristol-Myers Squibb, taxes
Puma Biotechnology Priced Like Takeover Target: Real M&A
Bloomberg
Tuesday, March 12, 2013 - 11:26am
tags:
Puma Biotechnology, M&A, AstraZeneca, Bristol-Myers Squibb, Takeda, Celgene, GSK
DOJ Investigating Sanofi Over Plavix Disclosure
Motley Fool
Tuesday, March 12, 2013 - 11:25am
tags:
Sanofi, DOJ, Plavix, Bristol-Myers Squibb
J&J Seeks EU Nod for Combo Drug
Yahoo/Zacks
Tuesday, March 12, 2013 - 11:24am
tags:
Europe, JNJ, diabetes, canagliflozin, metformin
Pfizer Gains Notable Win And A Loss In Recent Pipeline Updates
Seeking Alpha
Tuesday, March 12, 2013 - 11:23am
tags:
Pfizer, PF-00868544, Inspra
U.S. FDA says Zithromax can cause fatal irregular heart rhythm
Reuters
Tuesday, March 12, 2013 - 11:13am
tags:
FDA, Zithromax, abnormal heart rhythms, antiobiotics, Pfizer
Cubist Pharma buys out antibiotic partner Astellas for $25M-plus
Fierce Biotech
Monday, March 11, 2013 - 12:34pm
tags:
Cubist Pharma, Astellas, ceftolozane
Aeterna Zentaris to Discontinue Phase 3 Trial in Multiple Myeloma with Perifosine Following Data Safety Monitoring Board Recommendation
Yahoo
Monday, March 11, 2013 - 12:33pm
tags:
Aeterna Zentaris, Multiple Myeloma, perifosine
Vivus investor plots board takeover to rally Qsymia sales
Fierce Pharma
Monday, March 11, 2013 - 12:26pm
tags:
Vivus, Qsymia
3 Undiscovered Biotech Companies For The Healthcare Investor
Seeking Alpha
Monday, March 11, 2013 - 12:25pm
tags:
NeoStem, Antares, Galena Biopharma
PDL BioPharma forecasts greater 1Q royalties
Yahoo/AP
Monday, March 11, 2013 - 12:24pm
tags:
PDL Biopharma
After FDA Approval, A New And Bigger Catalyst Looms Closer For Immunogen
Seeking Alpha
Monday, March 11, 2013 - 11:09am
tags:
Immunogen, trastuzumab, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.